Literature DB >> 18206400

The immunohistochemical analysis of vascular endothelial growth factors A and C and microvessel density in gingival tissues of systemic sclerosis patients: their possible effects on gingival inflammation.

Onur Ozcelik1, M Cenk Haytac, Melek Ergin, Bulent Antmen, Gulsah Seydaoglu.   

Abstract

OBJECTIVE: In systemic sclerosis (SSC), certain abnormalities can occur in fibroblasts, endothelial cells, and immune system cells. Severe pathological changes such as visceral fibrosis and obliteration of the lumen of arteries may develop due to functional alterations of these cells. Because the vascular abnormality is a central mechanism of sclerosis, the aim of this study was to further investigate the impaired vascularity in the gingival tissues of SSC patients by means of immunohistochemistry using vascular endothelial growth factor A (VEGF-A), VEGF-C, and CD34 staining. STUDY
DESIGN: Thirteen SSC patients and 11 systemically healthy controls who had moderate gingivitis were included in the study. Gingival biopsies were obtained from the interdental papilla, and VEGF-A, VEGF-C, and CD34 analyses were done by using immunohistochemical methods.
RESULTS: Patients with scleroderma had higher levels of inflammatory infiltrate (P = .041) and microvessel density (P = .003) in their gingival biopsy samples. In contrast, when compared with the controls, the expressions of VEGF-A and VEGF-C were significantly lower in scleroderma patients (P = .033 and P = .015, respectively).
CONCLUSION: These findings may reflect the defective vascularity and the pronounced histological inflammation of the gingival tissues in systemic scleroderma and may provide a novel target for treatment methods for the gingival involvement in these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18206400     DOI: 10.1016/j.tripleo.2007.07.021

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  7 in total

1.  Effect of a multi-faceted intervention on gingival health among adults with systemic sclerosis.

Authors:  Hon K Yuen; Yanqiu Weng; Dipankar Bandyopadhyay; Susan G Reed; Renata S Leite; Richard M Silver
Journal:  Clin Exp Rheumatol       Date:  2011-05-12       Impact factor: 4.473

2.  Factors associated with gingival inflammation among adults with systemic sclerosis.

Authors:  H K Yuen; Y Weng; S G Reed; L M Summerlin; R M Silver
Journal:  Int J Dent Hyg       Date:  2013-04-24       Impact factor: 2.477

3.  Orofacial manifestations of systemic sclerosis.

Authors:  B J Veale; R Y Jablonski; T M Frech; J D Pauling
Journal:  Br Dent J       Date:  2016-09-23       Impact factor: 1.626

4.  Risk association between scleroderma disease characteristics, periodontitis, and tooth loss.

Authors:  Gaetano Isola; Ray C Williams; Alberto Lo Gullo; Luca Ramaglia; Marco Matarese; Vincenzo Iorio-Siciliano; Claudio Cosio; Giovanni Matarese
Journal:  Clin Rheumatol       Date:  2017-10-07       Impact factor: 2.980

Review 5.  [Pathogenesis of parodontitis in rheumatic diseases].

Authors:  J Detert; N Pischon; G-R Burmester; F Buttgereit
Journal:  Z Rheumatol       Date:  2010-03       Impact factor: 1.372

6.  Dental management of scleroderma patients using pentoxifylline plus vitamin E with and without TheraBite® to reduce trismus: Two case reports and brief review of literature.

Authors:  Daniel N Reed; David L Hall; James H Cottle; Katherine Frimenko; Christina K Horton; Farah Abu Sharkh; Rachel Beckett; Brandon Hernandez; Hannah Mabe; Shadee T Mansour; Sebastian A Rodriguez; Bradley Weprin; Leigh E Yarborough
Journal:  Clin Case Rep       Date:  2020-01-17

7.  The Role of Angiogenesis Factors in the Formation of Vascular Changes in Scleroderma by Assessment of the Concentrations of VEGF and sVEGFR2 in Blood Serum and Tear Fluid.

Authors:  Arleta Waszczykowska; Roman Goś; Elżbieta Waszczykowska; Bożena Dziankowska-Bartkowiak; Michał Podgórski; Piotr Jurowski
Journal:  Mediators Inflamm       Date:  2020-01-24       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.